American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 976-986 , June 2008

C-Reactive Protein Levels and Clinical Symptoms Following Gadolinium Administration in Hemodialysis Patients

  • Gisela Schieren, MD

      Affiliations

    • Department of Nephrology, University Hospital, Heinrich-Heine-University Düsseldorf, Germany
    • G.S. and F.T. contributed equally to this work.
    • Corresponding Author InformationAddress correspondence to Gisela Schieren, MD, Department of Nephrology, University Hospital, Heinrich-Heine-University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
    • ,
  • Faruk Tokmak, MD

      Affiliations

    • Department of Medicine 1, Marienhospital Herne, Ruhr-University Bochum, Münster, Germany
    • G.S. and F.T. contributed equally to this work.
    • ,
  • Lutz Lefringhausen, MD

      Affiliations

    • Department of Medicine 1, Marienhospital Herne, Ruhr-University Bochum, Münster, Germany
    • ,
  • Mark van Bracht, MD

      Affiliations

    • Department of Medicine 2, Marienhospital Herne, Ruhr-University Bochum, Münster, Germany
    • ,
  • Christian Perings, MD, PhD

      Affiliations

    • Department of Medicine 2, Marienhospital Herne, Ruhr-University Bochum, Münster, Germany
    • ,
  • Reinhardt Willers, PhD

      Affiliations

    • Department of Computation Statistics, Heinrich-Heine-University Düsseldorf, Münster, Germany
    • ,
  • Andreas Günsel, PhD

      Affiliations

    • Umweltprobenbank des Bundes, Münster, Germany.
    • ,
  • Fritz Kemper, MD

      Affiliations

    • Umweltprobenbank des Bundes, Münster, Germany.
    • ,
  • Gerhard Andreas Wiesmüller, MD

      Affiliations

    • Umweltprobenbank des Bundes, Münster, Germany.
    • ,
  • Lars Christian Rump, MD, PhD

      Affiliations

    • Department of Nephrology, University Hospital, Heinrich-Heine-University Düsseldorf, Germany

Received 10 July 2007 ,Accepted 25 February 2008.

References 

  1. Jordan RM, Mintz RD. Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol. 1995;164:743–744
  2. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media—Gadolinium chelates. Br J Radiol. 2006;79:368–371
  3. Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: A survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol. 1999;6:656–664
  4. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology. 1995;196:439–443
  5. Rahman SL, Harbinson MT, Mohiaddin R, Pennell DJ. Acute allergic reaction upon first exposure to gadolinium-DTPA: A case report. J Cardiovasc Magn Reson. 2005;7:849–851
  6. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 2000;12:205–213
  7. Arsenault TM, King BF, Marsh JW, et al. Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: Retrospective analysis of an initial experience. Mayo Clin Proc. 1996;71:1150–1154
  8. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: Results of a randomized study. Radiology. 2001;218:651–657
  9. Townsend RR, Cohen DL, Katholi R, et al. Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis. 2000;36:1207–1212
  10. Erley CM, Bader BD, Berger ED, et al. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant. 2004;19:2526–2531
  11. Sam AD, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 2003;38:313–318
  12. Idée JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol. 2006;20:563–576
  13. Schuhmann-Giampieri G, Krestin G. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol. 1991;26:975–979
  14. Tombach B, Bremer C, Reimer P, et al. Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure. Invest Radiol. 2000;35:35–40
  15. Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol. 1998;5:491–502
  16. Okada S, Katagiri K, Kumazaki T, Yokoyama H. Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiol. 2001;42:339–441
  17. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging. 1999;10:477–484
  18. Vorobiov M, Basok A, Tovbin D, Shnaider A, Katchko L, Rogachev B. Iron-mobilizing properties of the gadolinium-DTPA complex: Clinical and experimental observations. Nephrol Dial Transplant. 2003;18:884–887
  19. Davenport A, Whiting S. Profound pseudohypocalcemia due to gadolinium (Magnevist) contrast in a hemodialysis patient. Am J Kidney Dis. 2006;47:350–352
  20. Hayakawa K, Nakamura T, Shimizu Y. Calcium binding by gadolinium-based MR contrast agents. Radiat Med. 2005;23:545–549
  21. Normann PT, Joffe P, Martinsen I, Thomsen HS. Quantification of gadodiamide as Gd in serum, peritoneal dialysate and faeces by inductively coupled plasma atomic emission spectroscopy and comparative analysis by high-performance liquid chromatography. J Pharm Biomed Anal. 2000;22:939–947
  22. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647–649
  23. Cowper SE, Bucula R, Leboit PE. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis—Setting the record straight. Semin Arthritis Rheum. 2006;35:208–210

PII: S0272-6386(08)00529-5

doi: 10.1053/j.ajkd.2008.02.299

American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 976-986 , June 2008

Article Tools

* Image Usage & Resolution